Literature DB >> 16456709

Mcl-1: a highly regulated cell death and survival controller.

Hsin-Fang Yang-Yen1.   

Abstract

Mcl-1 is one member of the Bcl-2 family that has a very short protein half-life. Since its identification in 1993, a great number of studies have implicated that Mcl-1 plays an important role in various cell survival pathways. However, not until recently did the molecular mechanism by which Mcl-1 antagonizes apoptosis have begun to be elucidated. Mcl-1 is rapidly degraded in response to cell death signals and is immediately re-induced by survival stimuli. These results indicate that Mcl-1 plays an apical role in many cell death and survival regulatory programs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16456709     DOI: 10.1007/s11373-005-9064-4

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  38 in total

Review 1.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes.

Authors:  Emiko Fire; Stefano V Gullá; Robert A Grant; Amy E Keating
Journal:  Protein Sci       Date:  2010-03       Impact factor: 6.725

Review 3.  On to the road to degradation: atherosclerosis and the proteasome.

Authors:  Joerg Herrmann; Lilach O Lerman; Amir Lerman
Journal:  Cardiovasc Res       Date:  2009-10-08       Impact factor: 10.787

Review 4.  Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular disease.

Authors:  Feilong Wang; Amir Lerman; Joerg Herrmann
Journal:  Am J Cardiovasc Dis       Date:  2015-03-10

5.  Terfenadine induces anti-proliferative and apoptotic activities in human hormone-refractory prostate cancer through histamine receptor-independent Mcl-1 cleavage and Bak up-regulation.

Authors:  Wei-Ting Wang; Yen-Hui Chen; Jui-Ling Hsu; Wohn-Jenn Leu; Chia-Chun Yu; She-Hung Chan; Yunn-Fang Ho; Lih-Ching Hsu; Jih-Hwa Guh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-19       Impact factor: 3.000

6.  Nicotine enhances the antiapoptotic function of Mcl-1 through phosphorylation.

Authors:  Jinfeng Zhao; Meiguo Xin; Ton Wang; Yangde Zhang; Xingming Deng
Journal:  Mol Cancer Res       Date:  2009-11-10       Impact factor: 5.852

Review 7.  Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

Authors:  P H Sugden; S J Fuller; S C Weiss; A Clerk
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

Review 8.  Intrinsically disordered proteins in bcl-2 regulated apoptosis.

Authors:  Gilles J P Rautureau; Catherine L Day; Mark G Hinds
Journal:  Int J Mol Sci       Date:  2010-04-16       Impact factor: 5.923

9.  A molecular signature of proteinuria in glomerulonephritis.

Authors:  Heather N Reich; David Tritchler; Daniel C Cattran; Andrew M Herzenberg; Felix Eichinger; Anissa Boucherot; Anna Henger; Celine C Berthier; Viji Nair; Clemens D Cohen; James W Scholey; Matthias Kretzler
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

10.  RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro.

Authors:  Karen A Sutherland; Helena L Rogers; Denise Tosh; Michael J Rogers
Journal:  Arthritis Res Ther       Date:  2009-04-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.